Abstract
As a member of Rho GAPs family, Rho GTPase-Activating Protein 17 (ARHGAP17) regulates cytoskeletal recombination, cell polarity, cell proliferation and cell migration. ARHGAP17 is identified as a tumor suppressor in numerous cancer types. Current study intends to examine ARHGAP17 expression and its possible influence on the progression of hepatocellular carcinoma (HCC). ARHGAP17 expression in HCC cells was verified by RT-PCR and western blot. The proliferation and invasion of HCC cells were evaluated by CCK8 assay and transwell assay, respectively. The mRNA expression of ARHGAP17, PCNA, E-cadherin, N-cadherin, β-catenin, GSK-3β, Axin1, and APC were detected by RT-PCR. The protein expression of ARHGAP17, PCNA, E-cadherin, N-cadherin, β-catenin, p-β-catenin, GSK-3β, p-GSK-3β, Axin1, and APC were detected by western blot. ARHGAP17 staining was evaluated by immunohistochemistry and immunofluorescence. ARHGAP17 expression decreased significantly in HCC tumors and HCC cells after EMT. In response to overexpression of ARHGAP17, the capacities of HCC cell proliferation and invasion were reduced significantly, which were also confirmed by tumorigenesis experiments in vivo. With overexpression of ARHGAP17 in HCC cells, the p-GSK3β/GSK3β decreased, while the p-β-catenin/β-catenin, Axin1 and APC increased. In conclusion, ARHGAP17 inhibits HCC progression by inactivating the Wnt/β-catenin signaling pathway.
Similar content being viewed by others
Data Availability
All data generated or analyzed during this study are included in this published article.
References
Braun AC, Olayioye MA (2015) Rho regulation: Dlc proteins in space and time. Cell Signal 27:1643–1651
Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314
Ghouri YA, Mian I, Rowe JH (2017) Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog 16:1
Gomaa W, Al-Maghrabi H, Al-Maghrabi J (2021) The prognostic significance of immunostaining of Wnt signalling pathway molecules, E-cadherin and β-catenin in colorectal carcinomacolorectal carcinoma. Arab J Gastroenterol 22:137–145
Gumbiner BM (2005) Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6:622–634
Guo Q, Xiong Y, Song Y, Hua K, Gao S (2019) ARHGAP17 suppresses tumor progression and up-regulates P21 and P27 expression via inhibiting PI3K/AKT signaling pathway in cervical cancer. Gene 692:9–16
Hao Y, Baker D, Ten Dijke P (2019) TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci 20:2767
Jaffe AB, Hall A (2005) Rho gtpases: biochemistry and biology. Annu Rev Cell Dev Biol 21:247–269
Jiang W, He T, Liu S, Zheng Y, Xiang L, Pei X, Wang Z, Yang H (2018) The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer. J Hematol Oncol 11:139
Kim JG, Mahmud S, Min JK, Lee YB, Kim H, Kang DC, Park HS, Seong J, Park JB (2021) RhoA GTPase phosphorylated at tyrosine 42 by src kinase binds to β-catenin and contributes transcriptional regulation of vimentin upon Wnt3A. Redox Biol 40:101842
Klauzinska M, Castro NP, Rangel MC, Spike BT, Gray PC, Bertolette D, Cuttitta F, Salomon D (2020) The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition. Semin Cancer Biol 29:51–58
Kreider-Letterman G, Castillo A, Mahlandt EK, Goedhart J, Rabino A, Goicoechea S, Garcia-Mata R (2023) ARHGAP17 regulates the spatiotemporal activity of Cdc42 at invadopodia. J Cell Biol 222:e202207020
Malfettone A, Soukupova J, Bertran E et al (2017) Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma. Cancer Lett 392:39–50
McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73:4–13
Pan S, Deng Y, Fu J, Zhang Y, Zhang Z, Ru X, Qin X (2018) Tumor suppressive role of ARHGAP17 in colon cancer through Wnt/β-Catenin signaling. Cell Physiol Biochem 46:2138–2148
Park SY, Jeong MS, Han CW, Yu HS, Jang SB (2016) Structural and functional insight into proliferating cell nuclear antigen. J Microbiol Biotechnol 26:637–647
Rabaan AA, Al-Ahmed SH, Bazzi AM, Alfouzan WA, Alsuliman SA, Aldrazi FA, Haque S (2020) Overview of hepatitis C infection, molecular biology, and new treatment. J Infect Public Health 13:773–783
Ravi A, Kaushik S, Ravichandran A, Pan CQ, Low BC (2015) Epidermal growth factor activates the rho gtpase-activating protein (gap) deleted in liver cancer 1 via focal adhesion kinase and protein phosphatase 2a. J Biol Chem 290:4149–4162
Richnau N, Aspenström P (2001) Rich, a rho GTPase-activating protein domain-containing protein involved in signaling by Cdc42 and Rac1. J Biol Chem 27:35060–35070
Sengez B, Carr BI, Alotaibi H (2022) EMT and inflammation: crossroads in HCC. J Gastrointest Cancer. https://doi.org/10.1007/s12029-021-00801-z
Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, Wang Y, Gu S, Zhao X (2015) Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol Cancer 14:28
Sribenja S, Sawanyawisuth K, Kraiklang R, Wongkham C, Vaeteewoottacharn K, Obchoei S, Yao Q, Wongkham S, Chen C (2013) Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma. BMC Cancer 13:430
Tian Q, Gao H, Zhou Y, Zhu L, Yang J, Wang B, Liu P, Yang J (2022) RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with Merlin for binding to Amot-p80. Cell Death Dis 13:71
Tripathi BK, Qian X, Mertins P, Wang D, Papageorge AG, Carr SA, Lowy DR (2014) Cdk5 is a major regulator of the tumor suppressor dlc1. J Cell Biol 207:627–642
Wang J, He H, Jiang Q, Wang Y, Jia S (2020a) CBX6 promotes HCC metastasis via transcription factors Snail/Zeb1-mediated EMT mechanism. Onco Targets Ther 13:12489–12500
Wang L, Yang X, Wan L, Wang S, Pan J, Liu Y (2020b) ARHGAP17 inhibits pathological cyclic strain-induced apoptosis in human periodontal ligament fibroblasts via Rac1/Cdc42. Clin Exp Pharmacol Physiol 47:1591–1599
Wong SHM, Fang CM, Chuah LH, Leong CO, Ngai SC (2018) E-cadherin: its dysregulation in carcinogenesis and clinical implications. Crit Rev Oncol Hematol 121:11–22
Yang S, Liu Y, Li MY et al (2017) FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer. Mol Cancer 16:124
Zhang Y, Wang X (2020) Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol 13:165
Zhang J, Wang J, Zhou YF, Ren XY, Lin MM, Zhang QQ, Wang YH, Li X (2015) Rich1 negatively regulates the epithelial cell cycle, proliferation and adhesion by CDC42/RAC1-PAK1-Erk1/2 pathway. Cell Signal 27:1703–1712
Zhang Y, Li S, Zhou X, Sun J, Fan X, Guan Z, Zhang L, Yang Z (2019) Construction of a targeting nanoparticle of 3’,3”-bis-peptide-siRNA conjugate/mixed lipid with postinserted DSPE-PEG2000-cRGD. Mol Pharm 16:4920–4928
Funding
This work was supported by the Natural Science Foundation of Liaoning Province (2019-ZD-1062), the Joint Program of Key R&D Programs of Liaoning Province (2020JH2/10300168), Medical and Industrial Cross Joint Project of Liaoning Province (2022-YGJC-11) and the R&D Project for Major Technological Innovations of Shenyang City (19-112-4-081).
Author information
Authors and Affiliations
Contributions
HZ, SF, and WZ conceived and designed the experiments. CL, MS, FC analyzed the data. CL, YZ, BN, HZ performed the experiments. The manuscript was written by HZ, SF, and WZ. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The author reports no conflicts of interest in this work.
Ethical Approval
Current study was approved by the Ethics Committee of the General Hospital of Northern Theater Command of PLA.
Informed Consent
Written informed consent was obtained from the parents.
Consent for Publication
The authors affirm that human research participants provided informed consent for publication of the images.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fan, S., Zhao, H., Li, C. et al. ARHGAP17 Inhibits Hepatocellular Carcinoma Progression by Inactivation of Wnt/β-Catenin Signaling Pathway. Biochem Genet (2024). https://doi.org/10.1007/s10528-024-10822-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10528-024-10822-5